Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
News and Views
Nature Medicine  3, 954 - 955 (1997)
doi:10.1038/nm0997-954

Caspases: A treatment target for neurodegenerative disease?

David M. Holtzman1, 2 & Mohanish Deshmukh2

  1Department of Neurology, Washington University School of Medicine St. Louis, Missouri 63110, USA

  2Department of Molecular Biology & Pharmacology, Washington University School of Medicine St. Louis, Missouri 63110, USA

Treating neurodegenerative disease with drugs that inhibit the activity of caspases (proteases that regulate apoptosis) is a therapeutic avenue beginning to be explored.

REFERENCES
  1. Oppenheim, R.W. Cell death during the development of the nervous system. Annu. Rev. Neurosci. 14, 453−501 (1991). | Article | PubMed  | ISI | ChemPort |
  2. Kerr, J.F.R., Wyllie, A.H. & Currie, A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239−257 (1972). | PubMed  | ISI | ChemPort |
  3. Schwartz, L.M. & Milligan, C.E. Cold thoughts of death: the role of ICE proteases in neuronal death. Trends Neursci. 19, 555−562 (1996). | Article | ChemPort |
  4. Hara, H. et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and ex citotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94, 2007−2012 (1997). | Article | PubMed  | ChemPort |
  5. Johnson, E.M., Deckwerth, T.L. & Deshmukh, M. Neuronal death in developmental models: Possible implications in neuropathology. Brain Pathol. 6, 397−409 (1996). | PubMed  | ISI |
  6. Friedlander, R.M., Brown, R.H., Cagliardini, V., Wang, J. & Yuan, J. Inhibition of ICE slows ALS in mice. Nature. 388, 31 (1997). | Article | PubMed  | ChemPort |
  7. Kim, T.-W., Pettingell, W.H., Jung, Y.-K., Kovacs, D.M. & Tanzi, R.E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373−376 (1997). | Article | PubMed  | ISI | ChemPort |
  8. Ellis, R.E. & Horvitz, H.R. Genetic control of programmed cell death in the nematode. C. elegans. Cell 44, 817−829 (1986). | Article |
  9. Milligan, C.E. et al. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15, 385−393 (1995). | Article | PubMed  | ISI | ChemPort |
  10. Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368−372 (1996). | Article | PubMed  | ISI | ChemPort |
  11. Deshmukh, M. & Johnson, E.M., Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51, 897−906 (1997). | PubMed  | ISI | ChemPort |
  12. Werth, J.L., Cocabo, J., Deshmukh, M., Johnson, E.M. & Rothman, S. M. Physiological properties of SCG neurons prevented from undergoing programmed cell death. Soc. Neurosci. Abstr. (in the press).
  13. Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M. & Przedborski, S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559−562 (1997). | Article | PubMed  | ISI | ChemPort |
  14. Sagot, Y. et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of neurodegenerative disease. J. Neurosci. 15, 7727−7733 (1995). | PubMed  | ISI | ChemPort |
 Top
 Top
References
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1997 Nature Publishing Group | Privacy policy